Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003411797 | SCV004123157 | uncertain significance | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2023-11-13 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.239A>C (p.Glu80Ala) is a missense mutation. This variant has been seen three times in gnomADv2.1 at a MAF of 0.00001223 (0.001821%, 2/109846 in the European (Non-/finnish) sub-population). It does not meet any population criteria. The computational predictor REVEL gives a score of >0.50 (0.856). There is no predicted splice effect (SpliceAI=0). The variant has not been reported in patients with the RUNX1-defined phenotype. In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: No criteria are met. |
Labcorp Genetics |
RCV000814968 | SCV000955407 | uncertain significance | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2023-02-26 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change does not substantially affect RUNX1 function (PMID: 34166225). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RUNX1 protein function. ClinVar contains an entry for this variant (Variation ID: 658195). This missense change has been observed in individual(s) with clinical features of RUNX1-related conditions (PMID: 34166225). This variant is present in population databases (no rsID available, gnomAD 0.005%). This sequence change replaces glutamic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 80 of the RUNX1 protein (p.Glu80Ala). |
Baylor Genetics | RCV003467474 | SCV004209833 | uncertain significance | Acute myeloid leukemia | 2023-10-16 | criteria provided, single submitter | clinical testing |